pentobarbital will decrease the extent or impact of doravirine by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will decrease the level or effect of tamoxifen by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will reduce the extent or result of irinotecan liposomal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
pentobarbital decreases effects of hemin by pharmacodynamic antagonism. Use Caution/Monitor. Drugs that increase delta-aminolevulinic acid synthetase might lessen hemin outcome.
pentobarbital will decrease the level or effect of conjugated estrogens by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
pentobarbital will lessen the level or impact of indinavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
pentobarbital will lessen the extent or impact of quetiapine by affecting hepatic/intestinal enzyme CYP3A4 read more metabolism. Use Warning/Observe.
Monitor Closely (one)pentobarbital will decrease the level or effect of mestranol by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will decrease the extent or result of stiripentol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Stay clear of or Use Alternate Drug. If struggling to prevent coadministration of stiripentol with potent CYP3A4 inducers, raise stiripentol dose.
pentobarbital will lessen the extent or effect of conjugated estrogens, vaginal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
pentobarbital will enhance the stage or influence of ivosidenib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Coadministration of ivosidenib with solid CYP3A4 inducers diminished ivosidenib plasma concentrations.
pentobarbital will reduce the level or outcome of rabeprazole by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Mysterious.
Contraindicated (one)pentobarbital will minimize the extent or outcome of lorlatinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will decrease the extent or influence of ziprasidone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Mysterious.